TRIAL IN PROGRESS: PHASE 1 DOSE-FINDING STUDY TO EVALUATE SAFETY AND TOLERABILITY OF CVGBM IN PATIENTS WITH NEWLY DIAGNOSED AND SURGICALLY RESECTED MGMT-UNMETHYLATED GLIOBLASTOMA

被引：0

作者：

Tabatabai, G. ^{[1
]}

von Baumgarten, L. ^{[2
]}

van den Bent, M. ^{[3
]}

Burger, M. C. ^{[4
,5
]}

Freres, P. ^{[6
]}

Glas, M. ^{[7
]}

Hau, P. ^{[8
]}

Herrlinger, U. ^{[9
]}

Mildenberger, I. ^{[10
]}

Neyns, B. ^{[11
]}

Schaefer, H. ^{[12
]}

Seidel, C. ^{[13
]}

de Vos, F. ^{[14
]}

Galot, R. ^{[15
]}

Whenham, N. ^{[15
]}

Wick, A. ^{[16
]}

Falk, M. ^{[17
]}

Chama, L. de Freitas ^{[18
]}

Henze, J. ^{[17
]}

Kelemen, P. ^{[17
]}

Koch, S. D. ^{[18
]}

Lutz, J. ^{[18
]}

Heidenreich, R. ^{[18
]}

Roche, P. Romer ^{[17
]}

Rost, T. ^{[17
]}

Schoenborn-Kellenberger, O. ^{[17
]}

Gnad-Vogt, U. ^{[17
]}

机构：

[1] Tubingen Univ Hosp, Tubingen, Germany

[2] Ludwig Maximilians Univ Munchen, Neurosurg Clin & Polyclin, Munich, Germany

[3] Erasmus MC Canc Inst, Rotterdam, Netherlands

[4] Goethe Univ Hosp, Frankfurt, Germany

[5] Hosp Frankfurt, Ctr Neurologsurg & Neurooncol, Frankfurt, Germany

[6] Liege Univ Hosp, Frankfurt, Germany

[7] Univ Med Essen, Essen, Germany

[8] Univ Hosp Regensburg, Regensburg, Germany

[9] Univ Bonn, Bonn, Germany

[10] Mannheim Univ, Med Ctr, Mannheim, Germany

[11] Univ Hosp Brussels, Brussels, Belgium

[12] Univ Freiburg, Freiburg, Germany

[13] Univ Hosp Leipzig, Frankfurt, Germany

[14] Univ Med Ctr Utrecht, Frankfurt, Germany

[15] Univ St Luc Hosp, Brussels, Belgium

[16] Heidelberg Univ Hosp, Heidelberg, Germany

[17] CureVac SE, Wiesbaden, Germany

[18] CureVac SE, Tubingen, Germany

来源：

NEURO-ONCOLOGY | 2023年 / 25卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P06.09.B

引用

页码：47 / 47

页数：1

共 50 条

[31] NRG ONCOLOGY STUDY BN007: RANDOMIZED PHASE II/III TRIAL OF IPILIMIUMAB (IPI) PLUS NIVOLUMAB (NIVO) VS. TEMOZOLOMIDE (TMZ) IN MGMT-UNMETHYLATED (UMGMT) NEWLY DIAGNOSED GLIOBLASTOMA (NGBM)
Lassman, A. B.
Polley, M. C.
Iwamoto, F. M.
Sloan, A. E.
Wang, T. J. C.
Aldape, K. D.
Wefel, J. S.
Gondi, V.
Gutierrez, A. N.
Manasawala, M.
Gilbert, M. R.
Sulman, E. P.
Wolchok, J. D.
Greene, R. M.
Neil, E. C.
Lukas, R. V.
Goldlust, S. A.
Snuderl, M.
Dignam, J. J.
Won, M.
Movsas, B.
Mehta, M. P.
NEURO-ONCOLOGY, 2023, 25
[32] Topical sodium nitrite for chronic leg ulcers in patients with sickle cell anaemia: a phase 1 dose-finding safety and tolerability trial
Minniti, Caterina P.
Gorbach, Alexander M.
Xu, Dihua
Hon, Yuen Yi
Delaney, Kara-Marie
Seidel, Miles
Malik, Nitin
Peters-Lawrence, Marlene
Cantilena, Carly
Nichols, James S.
Mendelsohn, Laurel
Conrey, Anna
Grimes, George
Kato, Gregory J.
LANCET HAEMATOLOGY, 2014, 1 (03): : E95 - E103
[33] NRG ONCOLOGY STUDY BN007: RANDOMIZED PHASE II/III TRIAL OF IPILIMIUMAB (IPI) PLUS NIVOLUMAB (NIVO) VS. TEMOZOLOMIDE (TMZ) IN MGMT-UNMETHYLATED (UMGMT) NEWLY DIAGNOSED GLIOBLASTOMA (NGBM)
Lassman, Andrew
Polly, Mei-Yin
Iwamoto, Fabio
Sloan, Andrew
Wang, Tony
Aldape, Kenneth
Wefel, Jeffrey
Gondi, Vinai
Gutierrez, Alonson
Manasawala, Mohammed
Gilbert, Mark
Sulman, Erik
Wolchok, Jedd
Green, Richard
Neil, Elizabeth
Lukas, Rimas
Goldlust, Samuel
Snuderl, Matija
Dignam, James
Won, Minhee
Movsas, Benjamin
Mehta, Minesh
NEURO-ONCOLOGY, 2023, 25
[34] Radiotherapy and olaptesed pegol (NOX-A12) in partially resected or biopsy-only MGMT-unmethylated glioblastoma: Interim data from the German multicenter phase 1/2 GLORIA trial
Giordano, Frank Anton
Layer, Julian Philipp
Leonardelli, Sonia
Friker, Lea Lydia
Seidel, Clemens
Schaub, Christina
Turiello, Roberta
Sperk, Elena
Grau, Franziska
Paech, Daniel
Link, Barbara
Mueller, Wolf
Tabatabai, Ghazaleh
Sahm, Katharina
Kebir, Sied
Pietsch, Torsten
Glas, Martin
Bisdas, Sotiros
Herrlinger, Ulrich
Hoelzel, Michael
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[35] Phase I/II study of pazopanib and temozolomide in patients with newly diagnosed and resected glioblastoma: Pazoglio trial.
Saada-Bouzid, Esma
Frenel, Jean-Sebastien
Augereau, Paule
Bourg, Veronique
Gal, Jocelyn
Jacquinot, Rique
Gourmelon, Carole
Chateau, Yann
Barriere, Jerome
Bondiau, Pierre-Yves
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[36] IPAX-2: PHASE 1 SAFETY AND DOSE FINDING STUDY OF [131I]IPA PLUS STANDARD OF CARE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
Gan, Hui
Cerqueira, Brenda
Divlianska, Daniela
Cade, David
NEURO-ONCOLOGY, 2024, 26
[37] Cilengitide in patients with newly diagnosed glioblastoma multiforme and unmethylated MGMT gene promoter: Protocol of a multicenter, randomized, open-label, controlled phase II study
Nabors, L. B.
Fink, K.
Reardon, D. A.
Lesser, G. J.
Trusheim, J.
Raval, S. N.
Hicking, C.
Picard, M.
Mikkelsen, T.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[38] Safety and tolerability of AZD8055 in Japanese patients with advanced solid tumors; a dose-finding phase I study
Hajime Asahina
Hiroshi Nokihara
Noboru Yamamoto
Yasuhide Yamada
Yosuke Tamura
Kazunori Honda
Yoshitaka Seki
Yuko Tanabe
Hitoshi Shimada
Xiaojin Shi
Tomohide Tamura
Investigational New Drugs, 2013, 31 : 677 - 684
[39] ADJUVANT TROTABRESIB, A REVERSIBLE POTENT BROMODOMAIN AND EXTRATERMINAL INHIBITOR, PLUS TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA: INTERIM RESULTS FROM A PHASE 1B DOSE-FINDING STUDY
Vieito, Maria
Simonelli, Matteo
de Vos, Filip
Moreno, Victor
Geurts, Marjolein
Lorenzi, Elena
Macchini, Marina
van den Bent, Martin
Del Conte, Gianluca
de Jonge, Maja
Amoroso, Barbara
Sanchez-Perez, Tania
Zuraek, Marlene
Hanna, Bishoy
Aronchik, Ida
Filvaroff, Ellen
Mendez, Cristina
Wei, Xin
Nikolova, Zariana
Manuel Sepulveda, Juan
NEURO-ONCOLOGY, 2021, 23 : 71 - 71
[40] Safety and dose-finding trial of tadalafil administered for fetal growth restriction: A phase-1 clinical study
Kubo, Michiko
Tanaka, Hiroaki
Maki, Shintaro
Nii, Masafumi
Murabayashi, Nao
Osato, Kazuhiro
Kamimoto, Yuki
Umekawa, Takashi
Kondo, Eiji
Ikeda, Tomoaki
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2017, 43 (07) : 1159 - 1168

← 1 2 3 4 5 →